Skip to main content

Advertisement

Log in

Sarcopenia assessed with DXA and CT increases the risk of perioperative complications in patients with gastrectomy

  • Gastrointestinal
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

We investigated sarcopenia prevalence using various diagnostic criteria based on dual-energy X-ray absorptiometry (DXA) and computed tomography (CT) in gastric cancer patients who underwent gastrectomy, and evaluated the association between sarcopenia and perioperative complications.

Methods

This retrospective study included consecutive patients with gastric cancer who underwent gastrectomy, and preoperative DXA and CT from January 2013 to November 2020. Body composition was measured using DXA and CT. Height-adjusted DXA-based Appendicular Skeletal Muscle Mass Index (ASMI) and CT-based skeletal muscle cross-sectional area at the L3 level (SMI) were measured. Sarcopenia and sarcopenic obesity were defined using reported cutoff values. The chi-square test and univariate analysis were performed to determine risk factors for significant and severe perioperative complications (Clavien–Dindo Grades ≥ 2 and ≥ 3, respectively).

Results

In total, 77 males and 43 females aged 61.4 ± 11.0 years were included. ASMI and SMI were correlated (r = 0.819), but sarcopenia prevalence varied (20.0–63.3%), depending on the criteria applied. Univariate analysis revealed sarcopenia defined using the Asian Working Group on Sarcopenia (AWGS) criteria and sarcopenic obesity as risk factors for significant (odds ratio [OR] 2.76, p = 0.030 vs. OR 4.31, p = 0.002) and severe perioperative complications (OR 3.77, p = 0.036 vs. OR 4.78, p = 0.010). In subgroup analyses, sarcopenia and sarcopenic obesity were significantly associated with perioperative complications only in males.

Conclusion

Perioperative complication risk can be predicted from sarcopenia defined using the AWGS criteria and sarcopenic obesity measured using DXA and CT, particularly in males.

Key points

The prevalence of sarcopenia varies due to definition differences.

Sarcopenia and sarcopenic obesity are risk factors for significant and severe perioperative complications, particularly in males.

Our results suggest that physicians need to pay attention to perioperative complications after surgical treatment of male patients with sarcopenia and sarcopenic obesity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The datasets generated during the current study are not publicly available due to but are available from the corresponding author on reasonable request.

Abbreviations

ASMI:

Appendicular Skeletal Muscle Mass Index

AWGS:

Asian Working Group on Sarcopenia

BMI:

Body mass index

CD:

Clavien–Dindo classification

CI:

Confidential interval

CT:

Computed tomography

DM:

Diabetes mellitus

DXA:

Dual-energy X-ray absorptiometry

EWGSOP:

European Working Group on Sarcopenia in Older People

HTN:

Hypertension

HU:

Hounsfield unit

IWGS:

International Working Group on Sarcopenia

KNHANES:

Korean National Health and Nutrition Examination Survey

OR:

Odds ratio

SD:

Standard deviation

SMI:

Skeletal muscle index

TAM:

Total abdominal muscle area

References  

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clinic 68:394–424

    Google Scholar 

  2. Papenfuss WA, Kukar M, Oxenberg J et al (2014) Morbidity and mortality associated with gastrectomy for gastric cancer. Ann Surg Oncol 21:3008–3014

    Article  PubMed  Google Scholar 

  3. Chen F, Chi J, Liu Y, Fan L, Hu K (2022) Impact of preoperative sarcopenia on postoperative complications and prognosis of gastric cancer resection: a meta-analysis of cohort studies. Arch Gerontol Geriatr 98:104534

    Article  CAS  PubMed  Google Scholar 

  4. Shachar SS, Williams GR, Muss HB, Nishijima TF (2016) Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review. Eur J Cancer 57:58–67

    Article  PubMed  Google Scholar 

  5. Kawamura T, Makuuchi R, Tokunaga M et al (2018) Long-term outcomes of gastric cancer patients with preoperative sarcopenia. Ann Surg Oncol 25:1625–1632

    Article  PubMed  Google Scholar 

  6. Zhuang C-L, Shen X, Zou H-B et al (2020) EWGSOP2 versus EWGSOP1 for sarcopenia to predict prognosis in patients with gastric cancer after radical gastrectomy: analysis from a large-scale prospective study. Clin Nutr 39:2301–2310

    Article  PubMed  Google Scholar 

  7. Sakurai K, Kubo N, Tamura T et al (2017) Adverse effects of low preoperative skeletal muscle mass in patients undergoing gastrectomy for gastric cancer. Ann Surg Oncol 24:2712–2719

    Article  PubMed  Google Scholar 

  8. Cruz-Jentoft AJ, Bahat G, Bauer J et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16–31

    Article  PubMed  Google Scholar 

  9. Fielding RA, Vellas B, Evans WJ et al (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12:249–256

    Article  PubMed  Google Scholar 

  10. Chen L-K, Liu L-K, Woo J et al (2014) Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15:95–101

    Article  PubMed  Google Scholar 

  11. Studenski SA, Peters KW, Alley DE et al (2014) The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 69:547–558

  12. Zhuang C-L, Huang D-D, Pang W-Y et al (2016) Sarcopenia is an independent predictor of severe postoperative complications and long-term survival after radical gastrectomy for gastric cancer: analysis from a large-scale cohort. Medicine (Baltimore) 95:e3164

  13. Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205

    Article  PubMed  PubMed Central  Google Scholar 

  14. Lee C-m, Kang BK, Kim M (2021) Radiologic definition of sarcopenia in chronic liver disease. Life 11:86

    Article  PubMed  PubMed Central  Google Scholar 

  15. Martin L, Birdsell L, MacDonald N et al (2013) Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31:1539–1547

    Article  PubMed  Google Scholar 

  16. Chen LK, Woo J, Assantachai P et al (2020) Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc 21:300-307.e302

    Article  PubMed  Google Scholar 

  17. Kim KM, Lim S, Choi KM et al (2015) Sarcopenia in Korea: prevalence and clinical aspects. J Korean Geriatr Soc 19:1–8

    Article  CAS  Google Scholar 

  18. Prado CM, Lieffers JR, McCargar LJ et al (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9:629–635

    Article  PubMed  Google Scholar 

  19. Rollins KE, Javanmard-Emamghissi H, Awwad A, Macdonald IA, Fearon KC, Lobo DN (2017) Body composition measurement using computed tomography: does the phase of the scan matter? Nutrition 41:37–44

    Article  PubMed  Google Scholar 

  20. Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE (2008) A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 33:997–1006

    Article  PubMed  Google Scholar 

  21. Lou N, Chi C-H, Chen X-D et al (2017) Sarcopenia in overweight and obese patients is a predictive factor for postoperative complication in gastric cancer: a prospective study. Eur J Surg Oncol 43:188–195

  22. Nishigori T, Tsunoda S, Okabe H et al (2016) Impact of sarcopenic obesity on surgical site infection after laparoscopic total gastrectomy. Ann Surg Oncol 23:524–531

    Article  PubMed  Google Scholar 

  23. Rodrigues V, Landi F, Castro S et al (2021) Is sarcopenic obesity an indicator of poor prognosis in gastric cancer surgery? A cohort study in a western population. J Gastrointest Surg 25:1388–1403

    Article  CAS  PubMed  Google Scholar 

  24. Tegels JJ, Van Vugt JL, Reisinger KW et al (2015) Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes. J Surg Oncol 112:403–407

    Article  PubMed  Google Scholar 

  25. Zhang W-t, Lin J, Chen W-s et al (2018) Sarcopenic obesity is associated with severe postoperative complications in gastric cancer patients undergoing gastrectomy: a prospective study. J Gastrointest Surg 22:1861–1869

    Article  PubMed  Google Scholar 

  26. Fukuda Y, Yamamoto K, Hirao M et al (2016) Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy. Gastric Cancer 19:986–993

    Article  PubMed  Google Scholar 

  27. Wang S-L, Zhuang C-L, Huang D-D et al (2016) Sarcopenia adversely impacts postoperative clinical outcomes following gastrectomy in patients with gastric cancer: a prospective study. Ann Surg Oncol 23:556–564

    Article  PubMed  Google Scholar 

  28. Murnane LC, Forsyth AK, Koukounaras J et al (2021) Myosteatosis predicts higher complications and reduced overall survival following radical oesophageal and gastric cancer surgery. Eur J Surg Oncol 47:2295–2303

    Article  PubMed  Google Scholar 

  29. Zhuang CL, Shen X, Huang YY et al (2019) Myosteatosis predicts prognosis after radical gastrectomy for gastric cancer: a propensity score-matched analysis from a large-scale cohort. Surgery 166:297–304

    Article  PubMed  Google Scholar 

  30. Morimoto Y, Takahashi H, Fujii M et al (2019) Visceral obesity is a preoperative risk factor for postoperative ileus after surgery for colorectal cancer: single-institution retrospective analysis. Ann Gastroenterol Surg 3:657–666

    Article  PubMed  PubMed Central  Google Scholar 

  31. Saravana-Bawan B, Goplen M, Alghamdi M, Khadaroo RG (2021) The relationship between visceral obesity and post-operative complications: a meta-analysis. J Surg Res 267:71–81

    Article  PubMed  Google Scholar 

  32. van Vugt JL, van den Braak RRC, Schippers HJ et al (2018) Contrast-enhancement influences skeletal muscle density, but not skeletal muscle mass, measurements on computed tomography. Clin Nutr 37:1707–1714

    Article  PubMed  Google Scholar 

  33. Kim KM, Lim S, Choi SH et al (2014) Cardiometabolic implication of sarcopenia: the Korea National Health and Nutrition Examination Study (KNHANES) 2008–2010. IJC Metab Endoc 4:63–69

    Article  Google Scholar 

  34. Lindle RS, Metter EJ, Lynch NA et al (1997) Age and gender comparisons of muscle strength in 654 women and men aged 20–93 yr. J Appl Physiol (1985) 83:1581–1587

  35. Gale CR, Martyn CN, Cooper C, Sayer AA (2007) Grip strength, body composition, and mortality. Int J Epidemiol 36:228–235

    Article  PubMed  Google Scholar 

  36. Woo T, Yu S, Adams R, Visvanathan R (2017) The association between sarcopenia and quality of life is different in community dwelling older Australian men and women Geriatr. Med Care 2:1–6

    Google Scholar 

  37. Batsis JA, Mackenzie TA, Barre LK, Lopez-Jimenez F, Bartels SJ (2014) Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III. Eur J Clin Nutr 68:1001–1007

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by a grant from Hanyang University.

Funding

This work has received research funding by Hanyang University (HY-202200000001247).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Soo Jin Lee.

Ethics declarations

Guarantor

Dr. Soo Jin Lee takes full responsibility for the work as a whole, including the study design, access to data, and the decision to submit and publish the manuscript.

Conflict of interest

The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

Written informed consent was waived by the Institutional Review Board.

Ethical approval

The medial ethics review boards of the Hanyang University Medical Center (IRB No. 2022–06-038).

Methodology

• Retrospective

• Observational

• Performed at one institution

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 38 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, M., Lee, Cm., Kang, B.K. et al. Sarcopenia assessed with DXA and CT increases the risk of perioperative complications in patients with gastrectomy. Eur Radiol 33, 5150–5158 (2023). https://doi.org/10.1007/s00330-023-09401-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-023-09401-w

Keywords

Navigation